Assertio医疗 ASRT 深 沪
等待开盘 06-18 09:30:00 美东时间
23.50
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 23.50
- 总市值 1.52亿
- 52周最高 23.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.61
- 委 比 0.00%
- 总股本 646.22万
- 历史最高 393.90
- 量 比 0
- 振 幅 0.00%
- 历史最低 7.7055
- 每 手 1
- 风险率 4.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
06-10 01:19
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Assertio Agrees To Be Acquired By Zydus Worldwide For $23.50 Per Share In Cash
Assertio Holdings, Inc. (NASDAQ:ASRT) ("Assertio" or the "Company") today announced that, following an engagement process outlined under the revised merger agreement (the "Garda Merger Agreement") with Garda
05-13 20:01
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Assertio, Garda Therapeutics Enter Into Amended And Restated Agreement And Plan Of Merger; Garda Increases Offer To Acquire All Outstanding Shares Of Assertio To $21.80 Per Share In Cash With No Contingent Value Right
Increased All-Cash Tender Offer Price of $21.80 per share – or $153.2 MillionNew Tender Offer Price Represents 21.1% Premium to Prior OfferAssertio Holdings, Inc. (NASDAQ:ASRT) ("Assertio" or the "Company") today
05-04 20:07
Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-14 22:58
美股大行评级 | 小摩上调Lumentum控股目标价从565美元升至950美元；大小摩齐上调美国铝业目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13美元升至13.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8.25美元升至9美元
04-10 18:27
Lake Street Downgrades Assertio Hldgs to Hold, Lowers Price Target to $18
Lake Street analyst Thomas Flaten downgrades Assertio Hldgs (NASDAQ:ASRT) from Buy to Hold and lowers the price target from $45 to $18.
04-09 23:30
Cosette Pharmaceuticals Acquires The U.S. Sales And Distribution Rights For A Portfolio Of 7 Branded Products From Assertio Holdings
-- Adds Portfolio of Branded Products with $48.9 million in 2025 Net Sales and an Established Commercial Presence ---- SYMPAZAN® Establishes a Neurology Rare Disease Footprint within Cosette ---- Additional Brands
04-09 04:15
Top 2 Health Care Stocks That May Implode In April
Health care stocks warning for momentum investors. RSI indicator used to predict short term performance. Alkermes & Assertio overbought.
04-01 20:34
